Prof. David Araújo-Vilar, University of Santiago de Compostela, Spain
Prof. David Araujo Vilar has received honorary as board member, steering committee member, and/or speaker to Amryt Pharma, Regeneron, and Third Rock Ventures.
During the five past years, Corinne Vigouroux
has received fees for lectures from Ipsen, Lilly, and Amryt Pharma, for meeting
registration, travel and/or accommodation from Aegerion Pharmaceuticals, Amryt
Pharma, Laboratoires Servier, Novo-Nordisk and Sanofi, author fees from Performances
Médicales and Elsevier-Masson, and has received institutional research fundings
from Aegerion Pharmaceuticals.
Prof. Ferrucio Santini has worked as a consultant, participated in studies, and/or received travel funds from the following companies,
which are involved with lipodystrophy and/or diabetes: AstraZeneca, Aegerion/Amryt, Novo Nordisk.
Dr. Akinci is a compensated consultant for Amryt Pharmaceuticals. Dr. Akinci serves as a consultant, add board member, steering committee member, and/or speaker to Regeneron, Third Rock Ventures, AstraZeneca, Novonordisk, Boehringer Ingelheim, Sanofi, Novartis, Bilim Ilac, ARIS, and Servier.